Yasu, Japan

Takashi Ikari

This inventor holds 1 USPTO granted patent. Top assignee: Toray Industries, Inc.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Ikari. Retrieved from https://idiyas.com/inventor/takashi-ikari-p8u9436a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takashi Ikari: Innovator in Ophthalmic Preparations

Introduction

Takashi Ikari is a notable inventor based in Yasu-gun, Japan. He has made significant contributions to the field of ophthalmology through his innovative research and development of ophthalmic preparations. His work focuses on creating effective solutions for various ophthalmic diseases.

Latest Patents

Takashi Ikari holds a patent for an ophthalmic preparation that exhibits excellent pharmacological effects for treating various ophthalmic diseases. This preparation contains a 4,8-inter-m-phenylene prostaglandin I derivative, represented by a specific formula. His patent is a testament to his dedication to improving eye health and treatment options.

Career Highlights

Ikari is associated with Toray Industries, Inc., a leading company in the field of advanced materials and technologies. His role at the company has allowed him to collaborate with other experts and contribute to groundbreaking research in ophthalmic solutions.

Collaborations

Some of his notable coworkers include Yuzuru Matsumura and Tsutomu Nakamura. Their combined expertise has fostered a collaborative environment that enhances innovation and development in their projects.

Conclusion

Takashi Ikari's contributions to ophthalmic preparations highlight his commitment to advancing medical science. His innovative work continues to impact the field positively, providing new solutions for ophthalmic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…